Present status and future orientation of rivaroxaban application in patients with nonvulvular atrial fibrillation

被引：0
|
作者：
Huang, Sui [1 ]
Tang, Liang [1 ]
Hu, Yu [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Hematol, Wuhan 430022, Hubei, Peoples R China
来源：
THROMBOSIS RESEARCH | 2017年 / 156卷
关键词：
STROKE PREVENTION; ANTITHROMBOTIC THERAPY; WARFARIN; XANTUS; POPULATION;
D O I：
10.1016/j.thromres.2017.05.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：191 / 192
页数：2
相关论文
共 50 条
  • [41] Awareness and treatment of atrial fibrillation in older adults: the present and the future
    Lip, Gregory Y. H.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2013, 106 (05) : 393 - 394
  • [42] Atrial fibrillation ablation strategies and technologies: past, present, and future
    Buist, Thomas J.
    Zipes, Douglas P.
    Elvan, Arif
    CLINICAL RESEARCH IN CARDIOLOGY, 2021, 110 (06) : 775 - 788
  • [43] Catheter ablation of atrial fibrillation: Past, present, and future directions
    Yoshida, Kentaro
    Aonuma, Kazutaka
    JOURNAL OF ARRHYTHMIA, 2012, 28 (02) : 83 - 90
  • [44] Pharmacogenetics and pharmacokinetics of rivaroxaban in patients with atrial fibrillation and chronic kidney disease
    Shatalova, N. A.
    Sychev, D. A.
    Mirzoev, K. B.
    Kochetkov, A., I
    Ebzeeva, E. Y.
    Dashabylova, V. B.
    Bochkov, P. O.
    Tuchkova, S. N.
    Glagolev, S., V
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2023, 19 (05) : 470 - 478
  • [45] Rivaroxaban for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation and Active Cancer
    Laube, Eva S.
    Yu, Anthony
    Gupta, Dipti
    Miao, Yimei
    Samedy, Patrick
    Wills, Jonathan
    Harnicar, Stephen
    Soff, Gerald A.
    Mantha, Simon
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (02): : 213 - 217
  • [46] Rivaroxaban-associated intracranial hemorrhage in Saudi atrial fibrillation patients
    Alkhotani, Amal
    Alrishi, Nouf
    Alharthi, Meshari
    Alzahrani, Waleed
    MEDICINE, 2020, 99 (48) : E23316
  • [47] Outcomes With Rivaroxaban in Patients With Nonvalvular Atrial Fibrillation and Worsening Renal Function
    Nakagawara, Jyoji
    Ikeda, Takanori
    Ogawa, Satoshi
    Kitazono, Takanari
    Minematsu, Kazuo
    Miyamoto, Susumu
    Murakawa, Yuji
    Kidani, Yoko
    Okayama, Yutaka
    Sunaya, Toshiyuki
    Ohashi, Yohei
    Sakaguchi, Toshiaki
    Yamamoto, Noriyuki
    Yamanaka, Satoshi
    STROKE, 2019, 50
  • [48] The WATCHMAN left atrial appendage closure device for patients with atrial fibrillation: current status and future perspectives
    Wintgens, Lisette I. S.
    Maarse, Moniek
    Swaans, Martin J.
    Rensing, Benno J. W. M.
    Van Dijk, Vincent F.
    Boersma, Lucas V. A.
    EXPERT REVIEW OF MEDICAL DEVICES, 2020, 17 (07) : 615 - 625
  • [49] Clinical Safety Outcomes in Patients With Nonvalvular Atrial Fibrillation on Rivaroxaban and Diltiazem
    Bartlett, Jenna W.
    Renner, Elizabeth
    Mouland, Erin
    Barnes, Geoffrey D.
    Kuo, Liane
    Ha, Nghi B.
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (01) : 21 - 27
  • [50] RIVAROXABAN VERSUS WARFARIN IN AFRICAN AMERICAN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
    Coleman, Craig I.
    Thompson, Stanley
    Ashton, Veronica
    Palladino, Michael
    Bunz, Thomas
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 338 - 338
12345